BiotechTubeBiotechTube
Home/Pipeline/Comtan/Comtess

Comtan/Comtess

Parkinson's Disease

ApprovedCommercial

Key Facts

Indication
Parkinson's Disease
Phase
Approved
Status
Commercial
Company
Orion Corporation

About Orion Corporation

Orion Corporation is a leading Nordic pharmaceutical company founded in 1917 and headquartered in Espoo, Finland. The company operates through three main business areas: proprietary products, specialty products, and fermion (contract manufacturing). Orion has a strong presence in neurology, oncology, and critical care, with established commercial operations across Europe and expanding global reach.

View full company profile

Therapeutic Areas

OncologyNeurologyCritical CareParkinson's DiseaseSedation

Other Parkinson's Disease Drugs

DrugCompanyPhase
ABBV-951AbbViePhase 3
UCB0107UCBPhase 1
StalevoOrion CorporationApproved
CHRONOS-PD PlatformGrifolsResearch
GT-001 (Gene Therapy)Sumitomo PharmaPhase 1/2
CREXONT (Carbidopa/Levodopa)Amneal PharmaceuticalsApproved
BIIB122/DNL151Denali TherapeuticsPhase 3
ABBV-0805BioArctic ABPhase 1
BAN1202BioArctic ABPreclinical
ARV-102ArvinasPhase 1
AAV-GADMeiraGTxPreclinical/Phase 1
Not SpecifiedMinerva NeurosciencesClinical Stage